The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CASCADIAN THERAPEUTICS INC | COM | 14740B906 | 430 | 103,800 | SH | Call | SOLE | 103,800 | 0 | 0 | |
| GILEAD SCIENCES INC | COM | 375558903 | 33,960 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 28,720 | 1,025,700 | SH | SOLE | 1,025,700 | 0 | 0 | ||
| FORWARD PHARMA A/S | SPONSORED ADR | 34986J105 | 108 | 5,025 | SH | SOLE | 5,025 | 0 | 0 | ||
| GALAPAGOS NV | SPONSORED ADR | 36315X101 | 47,494 | 551,041 | SH | SOLE | 551,041 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 3,177 | 264,773 | SH | SOLE | 264,773 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 20,072 | 673,100 | SH | SOLE | 673,100 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 2,361 | 874,447 | SH | SOLE | 874,447 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,361 | 23,300 | SH | SOLE | 23,300 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 75,021 | 2,943,164 | SH | SOLE | 2,943,164 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 8,935 | 434,812 | SH | SOLE | 434,812 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | COM | 110122108 | 928 | 17,060 | SH | SOLE | 17,060 | 0 | 0 | ||
| CASCADIAN THERAPEUTICS INC | COM | 14740B606 | 12,420 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 859 | 118,000 | SH | SOLE | 118,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 13,729 | 794,969 | SH | SOLE | 794,969 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 1,299 | 382,000 | SH | SOLE | 382,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 11,543 | 2,537,026 | SH | SOLE | 2,537,026 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 1,036 | 42,009 | SH | SOLE | 42,009 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM | 46333X108 | 49,568 | 2,905,515 | SH | SOLE | 2,905,515 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 5,683 | 258,457 | SH | SOLE | 258,457 | 0 | 0 | ||
| KINDRED BIOSCIENCES INC | COM | 494577109 | 3,841 | 544,880 | SH | SOLE | 544,880 | 0 | 0 | ||
| KURA ONCOLOGY INC COM | COM | 50127T109 | 22,985 | 2,611,906 | SH | SOLE | 2,611,906 | 0 | 0 | ||
| ATYR PHARMA INC | COM | 002120103 | 8,024 | 2,292,659 | SH | SOLE | 2,292,659 | 0 | 0 | ||
| OREXIGEN THERAPEUTICS INC | COM | 686164302 | 405 | 117,726 | SH | SOLE | 117,726 | 0 | 0 | ||
| OVASCIENCE INC | COM | 69014Q101 | 6,568 | 3,512,332 | SH | SOLE | 3,512,332 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM | 75915K101 | 2,492 | 1,510,000 | SH | SOLE | 1,510,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC COM | COM | 87164F105 | 484 | 35,301 | SH | SOLE | 35,301 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 1,013 | 63,596 | SH | SOLE | 63,596 | 0 | 0 | ||
| VIVEVE MED INC | COM | 92852W204 | 1,583 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| VERSARTIS INC | COM | 92529L102 | 2,135 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 275 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 5,617 | 234,813 | SH | SOLE | 234,813 | 0 | 0 | ||
| THERAVANCE BIOPHARMA INC | NOTE | 88339KAA0 | 21,441 | 17,000,000 | PRN | SOLE | 17,000,000 | 0 | 0 | ||